Endurant Capital Management as of March 31, 2021
Portfolio Holdings for Endurant Capital Management
Endurant Capital Management holds 61 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Orthopediatrics Corp. (KIDS) | 5.0 | $19M | 396k | 48.75 | |
| Invacare Corp Note 5.000%11/1 | 5.0 | $19M | 20M | 0.97 | |
| Actinium Pharmaceuticals Call Option (ATNM) | 4.0 | $15M | 2.0M | 7.62 | |
| Bristol Myers Squibb (BMY) | 3.8 | $15M | 234k | 63.13 | |
| Adapthealth Corp Com Cl A (AHCO) | 3.8 | $15M | 400k | 36.76 | |
| Sanofi Sponsored Adr (SNY) | 3.5 | $14M | 272k | 49.46 | |
| Becton, Dickinson and (BDX) | 3.4 | $13M | 54k | 243.14 | |
| CVS Caremark Corporation (CVS) | 3.3 | $13M | 167k | 75.23 | |
| Astrazeneca Sponsored Adr (AZN) | 3.1 | $12M | 238k | 49.72 | |
| Laboratory Corp Amer Hldgs Com New (LH) | 3.0 | $12M | 45k | 255.02 | |
| Aclaris Therapeutics (ACRS) | 3.0 | $12M | 455k | 25.20 | |
| Anthem (ELV) | 3.0 | $11M | 32k | 358.95 | |
| Encompass Health Corp (EHC) | 2.9 | $11M | 134k | 81.90 | |
| Iovance Biotherapeutics (IOVA) | 2.6 | $9.8M | 311k | 31.66 | |
| Abbvie (ABBV) | 2.5 | $9.5M | 88k | 108.22 | |
| Molecular Templates | 2.3 | $9.0M | 709k | 12.62 | |
| Invacare Corporation | 2.3 | $8.9M | 1.1M | 8.02 | |
| McKesson Corporation (MCK) | 2.2 | $8.6M | 44k | 195.05 | |
| Bio Rad Labs Cl A (BIO) | 2.2 | $8.4M | 15k | 571.16 | |
| Aziyo Biologics Com Cl A (ELUT) | 2.1 | $8.1M | 584k | 13.82 | |
| Syneos Health Cl A | 2.1 | $8.0M | 106k | 75.85 | |
| Phasebio Pharmaceuticals (PHASQ) | 2.0 | $7.5M | 2.2M | 3.46 | |
| AmerisourceBergen (COR) | 1.9 | $7.4M | 63k | 118.08 | |
| Ocular Therapeutix (OCUL) | 1.9 | $7.2M | 439k | 16.41 | |
| Avantor (AVTR) | 1.8 | $7.0M | 241k | 28.93 | |
| Boston Scientific Corporation (BSX) | 1.6 | $6.1M | 159k | 38.65 | |
| Dariohealth Corp Com New (DRIO) | 1.6 | $6.1M | 318k | 19.26 | |
| Goodrx Hldgs Com Cl A (GDRX) | 1.4 | $5.3M | 137k | 39.02 | |
| Trillium Therapeutics Com New | 1.3 | $5.1M | 478k | 10.74 | |
| Centene Corporation (CNC) | 1.3 | $4.9M | 77k | 63.91 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 1.3 | $4.9M | 916k | 5.31 | |
| Johnson & Johnson (JNJ) | 1.2 | $4.7M | 29k | 164.34 | |
| Mereo Biopharma Group Ads (MREO) | 1.2 | $4.5M | 1.3M | 3.37 | |
| Insmed Com Par $.01 (INSM) | 1.2 | $4.5M | 132k | 34.06 | |
| Selecta Biosciences (RNAC) | 1.1 | $4.1M | 912k | 4.52 | |
| Calliditas Therapeutics Ab Sponsered Ads (CALT) | 1.0 | $3.9M | 142k | 27.56 | |
| Regulus Therapeutics Com New | 1.0 | $3.7M | 2.4M | 1.56 | |
| Albireo Pharma | 0.9 | $3.6M | 103k | 35.25 | |
| Medavail Holdings Ord | 0.8 | $3.2M | 230k | 14.00 | |
| Aptose Biosciences Com New | 0.8 | $3.1M | 518k | 5.98 | |
| Apricus Biosciences | 0.8 | $3.1M | 612k | 4.99 | |
| AngioDynamics (ANGO) | 0.8 | $3.0M | 129k | 23.40 | |
| Zoetis Cl A (ZTS) | 0.7 | $2.8M | 18k | 157.46 | |
| R1 Rcm | 0.7 | $2.7M | 108k | 24.68 | |
| Affimed Therapeutics B V | 0.7 | $2.6M | 331k | 7.91 | |
| DaVita (DVA) | 0.7 | $2.6M | 24k | 107.77 | |
| Owens & Minor (OMI) | 0.6 | $2.4M | 64k | 37.59 | |
| Gemini Therapeutics | 0.6 | $2.3M | 170k | 13.55 | |
| Immunic (IMUX) | 0.5 | $2.1M | 132k | 15.94 | |
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.5 | $2.1M | 58k | 35.64 | |
| Haemonetics Corporation (HAE) | 0.4 | $1.7M | 15k | 111.04 | |
| Esperion Therapeutics (ESPR) | 0.4 | $1.6M | 56k | 28.05 | |
| X4 Pharmaceuticals (XFOR) | 0.3 | $1.3M | 152k | 8.61 | |
| Bellus Health Com New | 0.3 | $1.2M | 314k | 3.84 | |
| Fate Therapeutics (FATE) | 0.3 | $1.1M | 13k | 82.42 | |
| Forte Biosciences (FBRX) | 0.2 | $946k | 28k | 34.29 | |
| Nevro (NVRO) | 0.2 | $899k | 6.4k | 139.55 | |
| Streamline Health Solutions (STRM) | 0.2 | $796k | 388k | 2.05 | |
| Bolt Biotherapeutics (BOLT) | 0.2 | $585k | 18k | 32.91 | |
| Tarsus Pharmaceuticals (TARS) | 0.1 | $456k | 14k | 32.24 | |
| Longboard Pharmaceuticals In (LBPH) | 0.1 | $267k | 16k | 16.35 |
